Hospital · Private company
Fox Chase Cancer Center
Track this companyFree. Adds Fox Chase Cancer Center to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Risk-Enabled Therapy After Initiating EV/Pembro for Bladder CancerPHASE2 · RECRUITING · started Oct 16, 2026ClinicalTrials.gov NCT07908979 · fetched Nov 12, 2026
- Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor TherapyPHASE2 · RECRUITING · started Jul 23, 2026ClinicalTrials.gov NCT07663422 · fetched Nov 12, 2026
- Prehabilitation in High-risk Oncologic SurgeryNA · RECRUITING · started Jul 15, 2026ClinicalTrials.gov NCT07638410 · fetched Nov 12, 2026
- Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced NeuropathyEARLY_PHASE1 · RECRUITING · started Oct 14, 2025ClinicalTrials.gov NCT07167446 · fetched Nov 12, 2026
- Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology PatientsNA · RECRUITING · started Aug 21, 2025ClinicalTrials.gov NCT07776704 · fetched Nov 12, 2026
- Adaptive Radiation for Locally Advanced Unresectable Pancreatic CancerNA · RECRUITING · started Aug 20, 2025ClinicalTrials.gov NCT06984562 · fetched Nov 12, 2026
- Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial CarcinomaPHASE2 · RECRUITING · started Jul 9, 2025ClinicalTrials.gov NCT07043972 · fetched Nov 12, 2026
- Testing Gene PilotLX With Latinx Cancer PatientsNA · ACTIVE_NOT_RECRUITING · started May 30, 2025ClinicalTrials.gov NCT06476938 · fetched Nov 12, 2026
- Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.NA · RECRUITING · started Feb 21, 2025ClinicalTrials.gov NCT06652347 · fetched Nov 12, 2026
- Communication About Sexual Health in Gynecologic CancerNA · RECRUITING · started Feb 20, 2025ClinicalTrials.gov NCT06904339 · fetched Nov 12, 2026
- Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)RECRUITING · started Aug 13, 2024ClinicalTrials.gov NCT06396533 · fetched Nov 12, 2026
- Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx CancerPHASE2 · RECRUITING · started Mar 14, 2023ClinicalTrials.gov NCT05800574 · fetched Nov 12, 2026
- Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 14, 2022ClinicalTrials.gov NCT05454280 · fetched Nov 12, 2026
- Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer PatientsPHASE1 · RECRUITING · started Jun 24, 2022ClinicalTrials.gov NCT05274048 · fetched Nov 12, 2026
- Redefining FOLFIORINOX in Older Pancreatic Cancer PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 22, 2022ClinicalTrials.gov NCT05360732 · fetched Nov 12, 2026
- Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine TumorsPHASE2 · RECRUITING · started Jan 21, 2022ClinicalTrials.gov NCT05263050 · fetched Nov 12, 2026
- A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 1, 2020ClinicalTrials.gov NCT04506554 · fetched Nov 12, 2026
- Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLCPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 8, 2020ClinicalTrials.gov NCT03527108 · fetched Nov 12, 2026
- Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLCPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 4, 2019ClinicalTrials.gov NCT03786692 · fetched Nov 12, 2026
- Organ Preservation in Early Rectal Cancer PatientsPHASE2 · ACTIVE_NOT_RECRUITING · started May 11, 2018ClinicalTrials.gov NCT03548961 · fetched Nov 12, 2026
- Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial CarcinomaACTIVE_NOT_RECRUITING · started Nov 27, 2017ClinicalTrials.gov NCT03291028 · fetched Nov 12, 2026
- Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 8, 2017ClinicalTrials.gov NCT03114527 · fetched Nov 12, 2026
- Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 13, 2017ClinicalTrials.gov NCT03125928 · fetched Nov 12, 2026
- Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell CarcinomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 12, 2017ClinicalTrials.gov NCT03172754 · fetched Nov 12, 2026
- Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the BladderNA · ACTIVE_NOT_RECRUITING · started Nov 11, 2016ClinicalTrials.gov NCT02968732 · fetched Nov 12, 2026